Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
|
|
Olema Pharmaceuticals, Inc. (OLMA)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 10/03/2023 |
4
| Harmon Cyrus (Director) has filed a Form 4 on Olema Pharmaceuticals, Inc.|
Txns:
| Sold 25,000 shares
@ $12.41, valued at
$310.3k
|
|
| 08/17/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/09/2023 |
4
| Harmon Cyrus (Director) has filed a Form 4 on Olema Pharmaceuticals, Inc.|
Txns:
| Sold 10,000 shares
@ $6.3, valued at
$63k
|
|
| 06/07/2023 |
4
| Harmon Cyrus (Director) has filed a Form 4 on Olema Pharmaceuticals, Inc.|
Txns:
| Sold 5,000 shares
@ $6.045, valued at
$30.2k
Sold 5,000 shares
@ $6.295, valued at
$31.5k
|
|
| 02/02/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/02/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/02/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/02/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/02/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/02/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/02/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/22/2022 |
4
| Bohen Sean (PRESIDENT AND CEO) has filed a Form 4 on Olema Pharmaceuticals, Inc.|
Txns:
| Granted 20,000 shares
@ $0 |
|
| 09/06/2022 |
4
| Kovacs Shane William Charles (CH. OPERATING & FINANCIAL OFF.) has filed a Form 4 on Olema Pharmaceuticals, Inc.|
Txns:
| Bought 20,000 shares
@ $0 |
|
| 06/17/2022 |
4
| Larson Yi (Director) has filed a Form 4 on Olema Pharmaceuticals, Inc.|
Txns:
| Granted 21,520 options to buy
@ $3.43, valued at
$73.8k
|
|
| 06/17/2022 |
4
| Horning Sandra (Director) has filed a Form 4 on Olema Pharmaceuticals, Inc.|
Txns:
| Granted 21,520 options to buy
@ $3.43, valued at
$73.8k
|
|
| 06/17/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/17/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/17/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/17/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/17/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/14/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/14/2022 |
4
| Horn Kinney (CHIEF BUSINESS OFFICER) has filed a Form 4 on Olema Pharmaceuticals, Inc.|
Txns:
| Sold 5,253 shares
@ $4.75, valued at
$25k
Exercised 5,253 options to buy
@ $2.064, valued at
$10.8k
|
|
| 02/14/2022 |
4
| Horn Kinney (CHIEF BUSINESS OFFICER) has filed a Form 4 on Olema Pharmaceuticals, Inc.|
Txns:
| Disposed/sold 5,251 shares
@ $0
Exercised 5,251 options to buy
@ $2.064, valued at
$10.8k
|
|
| 02/03/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/03/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/03/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/03/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/03/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/03/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/03/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/03/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/11/2022 |
4
| Horn Kinney (CHIEF BUSINESS OFFICER) has filed a Form 4 on Olema Pharmaceuticals, Inc.|
Txns:
| Sold 5,251 shares
@ $6.85, valued at
$36k
Exercised 5,251 options to buy
@ $2.064, valued at
$10.8k
|
|
| 12/14/2021 |
4
| Horn Kinney (CHIEF BUSINESS OFFICER) has filed a Form 4 on Olema Pharmaceuticals, Inc.|
Txns:
| Sold 5,251 shares
@ $10.39, valued at
$54.6k
Exercised 5,251 options to buy
@ $2.064, valued at
$10.8k
|
|
| 12/14/2021 |
4
| Myles David C. (CHIEF DEVELOPMENT OFFICER) has filed a Form 4 on Olema Pharmaceuticals, Inc.|
Txns:
| Sold 10,000 shares
@ $10.3, valued at
$103k
|
|
|
|
|